VERADERMICS, INCORPORATED reports a Return on Equity (ROE) of -17.13%.

What is MANE's dividend yield?

VERADERMICS, INCORPORATED offers a dividend yield of 0.00%.

What is MANE's Deepscope Quality Score?

Deepscope rates MANE's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy MANE?

Deepscope's AI Timing Score for MANE is 70 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does MANE belong to?

VERADERMICS, INCORPORATED is classified under the Healthcare >> Biotechnology sector on the NYSE exchange.

MANE (NYSE) Stock Analysis | VERADERMICS, INCORPORATED

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-10 | FS: 2026-03-31)

MANE

VERADERMICS, INCORPORATED

US:NYSE STOCK Healthcare >> Biotechnology News 90

USD 92.98

-2.93 (-3.05%) Day Change

Watchlist Portfolio Compare Chart

0.02

D/E

-17.1%

ROE

-16.8%

ROA

0.00%

Div Yield

VERADERMICS, INCORPORATED
TYPE: STOCK
MARKET: NYSE

Compare Watchlist Myport

USD 92.98 Price -2.93 (-3.05%) Day Change	NEWS SCORE: 90

MANE, the overall quality is not good ( Quality = 31) but the timing to buy is ...(Sign In to See)...

Loading chart...

31 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Acceleration of ROA growth rate is below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...

Quality Factors

38%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	90
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	92.98
PBV / Sector	10.23 / 4.79
Earning Per Share	-1.56

PE / Sector	N/A / 17.89
PEG or PE/Growth / Sector	N/A / 0.56
Average 1M Daily Value	42.54 M GREAT
Average 1W Daily Value	41.19 M GREAT

Timing Factors

42%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

37%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	N/A / 468.85
NPM Average (%) / Sector	N/A / -1,531.69
NPM Change Average (%) / Sector	N/A / 5,028.65
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-16.84 / 31.69
ROA Average (%) / Sector	-49.17 / -353.18
ROA Change Average (%) / Sector	-36.84 / 5,214.65
ROE (%) / Sector	-17.13 / 10.58
ROE Average (%) / Sector	-30.14 / 27.64
ROE Change Average (%) / Sector	-135.35 / 2,048.88
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.05
Dividend Average (%) / Sector	N/A / 16.49
Dividend Change Average (%) / Sector	N/A / 4.77

Registration Details

Analyze Date	2026-06-11 09:55:18
Symbol	MANE
Name	VERADERMICS, INCORPORATED
Sector	Healthcare >> Biotechnology
Market	NYSE
Listed Shares	41.78 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	4,006.99 / 8,963.32

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 470 James Street, New Haven, CT, United States, 06513

Phone: (228) 372-3376

Website: https://www.veradermics.com

Sector: Healthcare >> Biotechnology

Description: Veradermics, Incorporated, a clinical-stage biopharmaceutical company, focused on developing novel therapeutics for dermatologic and aesthetic conditions. The company develops treatments for Pattern Hair Loss affecting adults and children. The company's products include VDPHL01, an oral, non-hormonal treatment for men and women with PHL for chronic hair loss therapy. Additionally, it engages in the development of VDMN, a dissolvable microarray patch technology for immunotherapy of common warts; VDAA for the treatment of alopecia areata; and VDMC for the treatment of molluscum contagiosum. Its products are used for the treatment of androgenetic alopecia, common warts, molluscum contagiosum, alopecia areata, and atopic dermatitis. The company serves healthcare providers and clinicians treating dermatologic and aesthetic conditions in both adult and pediatric populations, as well as the broader medical and clinical research community involved in dermatology. Veradermics, Incorporated was incorporated in 2019 and is headquartered in New Haven, Connecticut.